Income Statement Shivalik Rasayan Limited

Stocks

SHIVALIK

INE788J01021

Agricultural Chemicals

Delayed Bombay S.E. 03:32:30 01/10/2026 pm IST			5-day change	1st Jan Change
392.55 ^INR	-2.24%		-4.09%	+10.31%

14/08	Shivalik Rasayan Limited Reports Earnings Results for the First Quarter Ended June 30, 2026	CI
23/07	Shivalik Rasayan Limited announced that it expects to receive INR 152.25 million in funding from Bishnoi Exports Private Limited, Growel Remedies Limited, Kim Ginnerup ApS and other investors	CI

fd8be01023.CQFHwlIACnYaytz0ACLhH19owOjmZPVtlV3D9P80YoA.UXsx-wJQOUV5ouuzQXuRLx0bjLCxEpte-WmJwZR5CvhbZzeXBjZOM1u-tw

Published financial data: SHIVALIK RASAYAN LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Revenues	206.97Cr	233.99Cr	271.54Cr	309.55Cr	361.62Cr
Other Revenues, Total	-	1T	-	-	-
Total Revenues	206.97Cr	233.99Cr	271.54Cr	309.55Cr	361.62Cr
Cost of Goods Sold, Total	94Cr	114.72Cr	139.84Cr	160.41Cr	188.37Cr
Gross Profit	112.85Cr	119.27Cr	131.7Cr	149.14Cr	173.25Cr
Selling General & Admin Expenses, Total	31Cr	38Cr	49Cr	57Cr	64Cr
Depreciation & Amortization - (IS)	11Cr	12Cr	12Cr	16Cr	19Cr
Other Operating Expenses	35Cr	38Cr	43Cr	52Cr	63Cr
Other Operating Expenses, Total	77Cr	88Cr	104.66Cr	124.71Cr	146.25Cr
Operating Income	36Cr	31Cr	27Cr	24Cr	27Cr
Interest Expense, Total	-2.5Cr	-4.34Cr	-7.63Cr	-9.33Cr	-9.6Cr
Interest And Investment Income	2.12Cr	2.92Cr	2.36Cr	2.5Cr	2.64Cr
Net Interest Expenses	-37.46L	-1.42Cr	-5.26Cr	-6.83Cr	-6.96Cr
Currency Exchange Gains (Loss)	1.45Cr	1.48Cr	1.39Cr	70.59L	54.39L
Other Non Operating Income (Expenses)	2L	14.76L	11.96L	5.1Cr	89.35L
EBT, Excl. Unusual Items	37Cr	32Cr	23Cr	23Cr	21Cr
Gain (Loss) On Sale Of Assets	-4.78T	-68T	3T	-	-
EBT, Incl. Unusual Items	37Cr	32Cr	23Cr	23Cr	21Cr
Income Tax Expense	2.7Cr	1.83Cr	5.15Cr	2.98Cr	3.51Cr
Earnings From Continuing Operations	34Cr	30Cr	18Cr	20Cr	18Cr
Net Income to Company	34Cr	30Cr	18Cr	20Cr	18Cr
Minority Interest	-8.65Cr	-8.6Cr	-5.41Cr	-3.73Cr	-5.57Cr
Net Income - (IS)	26Cr	21Cr	13Cr	17Cr	12Cr
Net Income to Common Incl Extra Items	26Cr	21Cr	13Cr	17Cr	12Cr
Net Income to Common Excl. Extra Items	26Cr	21Cr	13Cr	17Cr	12Cr
Per Share Items
Net EPS - Basic	18.12	14.66	8.35	10.6	7.87
Basic EPS - Continuing Operations	18.12	14.66	8.35	10.6	7.87
Basic Weighted Average Shares Outstanding	1.41Cr	1.45Cr	1.52Cr	1.58Cr	1.58Cr
Net EPS - Diluted	18.12	14.66	8.35	10.6	7.87
Diluted EPS - Continuing Operations	18.12	14.66	8.35	10.6	7.87
Diluted Weighted Average Shares Outstanding	1.41Cr	1.45Cr	1.52Cr	1.58Cr	1.58Cr
Normalized Basic EPS	10.22	7.73	6	6.92	4.99
Normalized Diluted EPS	10.22	7.73	6	6.92	4.99
Dividend Per Share	0.5	0.5	0.5	0.5	0.5
Payout Ratio	2.69	9.37	15.81	12.28	17.29
Supplemental Items
EBITDA	47Cr	43Cr	31Cr	40Cr	46Cr
EBITA	36Cr	31Cr	27Cr	24Cr	27Cr
EBIT	36Cr	31Cr	27Cr	24Cr	27Cr
Total Revenues (As Reported)	218.46Cr	239.11Cr	276.96Cr	320.08Cr	372.08Cr
Effective Tax Rate - (Ratio)	7.32	5.78	22.13	12.75	16.33
Total Current Taxes	3.98Cr	3.7Cr	6.08Cr	5.5Cr	4.21Cr
Total Deferred Taxes	-1.27Cr	-1.87Cr	-93.15L	-2.52Cr	-69.98L
Normalized Net Income	14Cr	11Cr	9.14Cr	11Cr	7.85Cr
Interest on Long-Term Debt	92.93L	1.07Cr	2.49Cr	2.31Cr	1.59Cr
Supplemental Operating Expense Items
Advertising Expense	59.62L	79.29L	2.01Cr	1.64Cr	3.33Cr
Selling and Marketing Expenses	59.62L	79.29L	2.01Cr	1.64Cr	3.33Cr
General and Administrative Expenses	56.59L	54.24L	61.11L	59.56L	51.57L
Research And Development Expense From Footnotes	8.12Cr	7.04Cr	6.59Cr	6.15Cr	8.62Cr

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Assets
Cash And Equivalents	71Cr	31Cr	38Cr	28Cr	34Cr
Short Term Investments	-	-	-	-	-
Total Cash And Short Term Investments	71Cr	31Cr	38Cr	28Cr	34Cr
Accounts Receivable, Total	70Cr	85Cr	87Cr	96Cr	115.14Cr
Other Receivables	4.64Cr	3.01Cr	3.08Cr	2.76Cr	2.15Cr
Notes Receivable	1.48Cr	3.03Cr	3.5Cr	3.24Cr	2.61Cr
Total Receivables	76Cr	91Cr	93Cr	102.11Cr	119.9Cr
Inventory	38Cr	75Cr	101.83Cr	117.7Cr	146.87Cr
Prepaid Expenses	81.28L	23.53L	26.93L	59.23L	95.81L
Other Current Assets, Total	54Cr	65Cr	61Cr	66Cr	80Cr
Total Current Assets	239.9Cr	261.56Cr	293.91Cr	314.64Cr	382.08Cr
Gross Property Plant And Equipment	273.12Cr	335.28Cr	402.22Cr	423.32Cr	440.01Cr
Accumulated Depreciation	-50Cr	-61Cr	-72Cr	-87Cr	-106.01Cr
Net Property Plant And Equipment	223.59Cr	274.63Cr	329.91Cr	335.9Cr	334Cr
Other Intangibles, Total	35.98L	89.77L	89.83L	74.23L	57.16L
Loans Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	1.24Cr	3.11Cr	4.01Cr	6.56Cr	7.24Cr
Deferred Charges Long-Term	15Cr	31Cr	54Cr	71Cr	89Cr
Other Long-Term Assets, Total	7.76Cr	7.51Cr	9.39Cr	5.34Cr	6.25Cr
Total Assets	488.26Cr	578.24Cr	692.43Cr	734.29Cr	818.87Cr
Liabilities
Accounts Payable, Total	51Cr	59Cr	45Cr	55Cr	67Cr
Accrued Expenses, Total	6.45Cr	8.11Cr	11Cr	15Cr	17Cr
Short-term Borrowings	30Cr	45Cr	52Cr	77Cr	87Cr
Current Portion of Long-Term Debt	2.69Cr	7.8Cr	9.88Cr	11Cr	9.15Cr
Current Income Taxes Payable	7.6Cr	6.25Cr	5.93Cr	6.22Cr	4.61Cr
Unearned Revenue Current, Total	1.46Cr	2.22Cr	35.9L	15.19L	34.15L
Other Current Liabilities	14Cr	16Cr	34Cr	13Cr	4.13Cr
Total Current Liabilities	113.16Cr	143.56Cr	158.46Cr	178.2Cr	190.18Cr
Long-Term Debt	8.38Cr	13Cr	24Cr	16Cr	26Cr
Pension & Other Post Retirement Benefits	1.29Cr	1.53Cr	1.57Cr	2.4Cr	96.02L
Deferred Tax Liability Non Current	-	-	-	-31T	-
Other Non Current Liabilities	74.87L	86.07L	80.23L	95.86L	2.44Cr
Total Liabilities	123.58Cr	158.96Cr	184.8Cr	198.05Cr	219.76Cr
Common Stock, Total	7.24Cr	7.24Cr	7.78Cr	7.88Cr	7.88Cr
Additional Paid In Capital	194.17Cr	224.54Cr	313.74Cr	327.25Cr	327.25Cr
Retained Earnings	90Cr	118.27Cr	135.23Cr	154.11Cr	170.02Cr
Comprehensive Income and Other	-3.79Cr	10Cr	51Cr	47Cr	94Cr
Total Common Equity	287.19Cr	360.39Cr	507.63Cr	536.24Cr	599.1Cr
Minority Interest	77Cr	59Cr	-	-	-
Total Equity	364.68Cr	419.28Cr	507.63Cr	536.24Cr	599.1Cr
Total Liabilities And Equity	488.26Cr	578.24Cr	692.43Cr	734.29Cr	818.87Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	1.45Cr	1.45Cr	1.56Cr	1.58Cr	1.58Cr
ECS Total Common Shares Outstanding	1.45Cr	1.45Cr	1.56Cr	1.58Cr	1.58Cr
Book Value / Share	198.21	248.73	326.23	340.46	380.38
Tangible Book Value	286.83Cr	359.49Cr	506.73Cr	535.49Cr	598.53Cr
Tangible Book Value Per Share	197.96	248.11	325.66	339.99	380.01
Total Debt	41Cr	66Cr	86Cr	104.73Cr	122.79Cr
Net Debt	-30Cr	35Cr	48Cr	77Cr	88Cr
Minority Interest, Total (Incl. Fin. Div)	77Cr	59Cr	-	-	-
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	26Cr	43Cr	49Cr	46Cr	60Cr
Inventories - Work In Process, Total	1.43Cr	1.2Cr	17Cr	16Cr	4.6Cr
Inventories - Finished Goods, Total	11Cr	31Cr	36Cr	56Cr	82Cr
Inventories - Others	7L	12.45L	-	-	-
Land - (BS)	24Cr	24Cr	23Cr	24Cr	24Cr
Buildings, Total	93Cr	93Cr	94Cr	123.52Cr	124.94Cr
Machinery, Total	140.62Cr	160.43Cr	156.3Cr	239.23Cr	254.48Cr
Full Time Employees	237	256	267	275	342

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Net Income	26Cr	21Cr	13Cr	17Cr	12Cr
Depreciation & Amortization - CF	11Cr	11Cr	4.27Cr	16Cr	19Cr
Depreciation & Amortization, Total	11Cr	11Cr	4.27Cr	16Cr	19Cr
Amortization of Deferred Charges, Total - (CF)	10L	11.03L	28.47L	15.6L	17.07L
(Gain) Loss From Sale Of Asset	-12.11T	-68T	3T	-	-
Other Operating Activities, Total	8.58Cr	6.71Cr	20Cr	11Cr	14Cr
Change In Accounts Receivable	-1.16Cr	-15Cr	-1.97Cr	-9.37Cr	-19Cr
Change In Inventories	-28Cr	-37Cr	-27Cr	-16Cr	-29Cr
Change In Accounts Payable	11Cr	9.87Cr	-13Cr	14Cr	14Cr
Change in Other Net Operating Assets	-16Cr	-17Cr	-3.08Cr	-41Cr	-44Cr
Cash from Operations	11Cr	-19Cr	-8.08Cr	-9.2Cr	-34Cr
Capital Expenditure	-25Cr	-63Cr	-68Cr	-23Cr	-17Cr
Investment in Marketable and Equity Securities, Total	-	-9.93Cr	-8.49Cr	-1.04Cr	-6.62Cr
Other Investing Activities, Total	1.61Cr	2.39Cr	1.84Cr	2.57Cr	2.09Cr
Cash from Investing	-23Cr	-71Cr	-74Cr	-21Cr	-21Cr
Short Term Debt Issued, Total	12Cr	15Cr	7.41Cr	25Cr	10Cr
Long-Term Debt Issued, Total	-	4.63Cr	11Cr	-	9.68Cr
Total Debt Issued	12Cr	19Cr	18Cr	25Cr	20Cr
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-2.73Cr	-	-	-7.47Cr	-
Total Debt Repaid	-2.73Cr	-	-	-7.47Cr	-
Issuance of Common Stock	65Cr	31Cr	78Cr	14Cr	45Cr
Common Dividends Paid	-68.9L	-1.99Cr	-2.01Cr	-2.05Cr	-2.14Cr
Common & Preferred Stock Dividends Paid	-68.9L	-1.99Cr	-2.01Cr	-2.05Cr	-2.14Cr
Other Financing Activities, Total	3.74Cr	1.53Cr	-4.64Cr	-9.33Cr	-98.76L
Cash from Financing	78Cr	50Cr	89Cr	21Cr	62Cr
Miscellaneous Cash Flow Adjustments	-	-	-	1T	1T
Net Change in Cash	66Cr	-40Cr	7.07Cr	-9.77Cr	6.4Cr
Supplemental Items
Cash Interest Paid	2.5Cr	4.34Cr	7.63Cr	9.33Cr	9.6Cr
Cash Income Tax Paid (Refund)	6.2Cr	5.67Cr	4.32Cr	2.75Cr	2.84Cr
Levered Free Cash Flow	-28Cr	-86Cr	-71Cr	-34Cr	-45Cr
Unlevered Free Cash Flow	-26Cr	-83Cr	-66Cr	-29Cr	-39Cr
Change In Net Working Capital	34Cr	51Cr	20Cr	37Cr	57Cr
Net Debt Issued / Repaid	9.77Cr	19Cr	18Cr	18Cr	20Cr

Fiscal Period: March	2022 (INR)	2023 (INR)	2024 (INR)	2025 (INR)	2026 (INR)
Profitability
Return on Assets	5.27	3.69	2.66	2.14	2.17
Return on Total Capital	6.45	4.42	3.13	2.47	2.48
Return On Equity %	10.98	7.61	3.91	3.91	3.17
Return on Common Equity	10.98	6.56	2.74	3.2	2.18
Margin Analysis
Gross Profit Margin %	54.53	50.97	48.5	48.18	47.91
SG&A Margin	14.97	16.36	18.16	18.5	17.81
EBITDA Margin %	22.6	18.36	11.53	12.94	12.61
EBITA Margin %	17.33	13.45	9.96	7.89	7.47
EBIT Margin %	17.33	13.45	9.96	7.89	7.47
Income From Continuing Operations Margin %	16.55	12.75	6.68	6.6	4.97
Net Income Margin %	12.37	9.08	4.68	5.39	3.43
Net Avail. For Common Margin %	12.37	9.08	4.68	5.39	3.43
Normalized Net Income Margin	6.98	4.78	3.37	3.52	2.17
Levered Free Cash Flow Margin	-13.32	-36.66	-26.09	-11.12	-12.31
Unlevered Free Cash Flow Margin	-12.56	-35.5	-24.34	-9.23	-10.65
Asset Turnover
Asset Turnover	0.49	0.44	0.43	0.43	0.47
Fixed Assets Turnover	0.96	0.94	0.9	0.93	1.08
Receivables Turnover (Average Receivables)	2.98	3.02	3.17	3.39	3.42
Inventory Turnover (Average Inventory)	3.93	2.03	1.58	1.46	1.42
Short Term Liquidity
Current Ratio	2.12	1.82	1.85	1.77	2.01
Quick Ratio	1.28	0.83	0.8	0.71	0.8
Operating Cash Flow to Current Liabilities	0.1	-0.13	-0.05	-0.05	-0.18
Days Sales Outstanding (Average Receivables)	122.43	120.72	115.59	107.81	106.61
Days Outstanding Inventory (Average Inventory)	92.99	179.97	231.38	249.76	256.32
Average Days Payable Outstanding	133.66	133.4	114.24	103.75	102.53
Cash Conversion Cycle (Average Days)	81.76	167.3	232.73	253.82	260.41
Long Term Solvency
Total Debt/Equity	11.28	15.62	16.93	19.53	20.5
Total Debt / Total Capital	10.13	13.51	14.48	16.34	17.01
LT Debt/Equity	2.3	3.1	4.72	3.08	4.37
Long-Term Debt / Total Capital	2.06	2.68	4.04	2.57	3.63
Total Liabilities / Total Assets	25.31	27.49	26.69	26.97	26.84
EBIT / Interest Expense	14.37	7.24	3.55	2.62	2.81
EBITDA / Interest Expense	18.75	9.89	4.11	4.29	4.75
(EBITDA - Capex) / Interest Expense	8.74	-4.67	-4.76	1.87	3.01
Total Debt / EBITDA	0.88	1.52	2.75	2.62	2.69
Net Debt / EBITDA	-0.63	0.81	1.54	1.92	1.94
Total Debt / (EBITDA - Capex)	1.89	-3.23	-2.37	6.02	4.25
Net Debt / (EBITDA - Capex)	-1.36	-1.72	-1.33	4.41	3.06
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	5.82	13.06	16.05	14	16.82
Gross Profit, 1 Yr. Growth %	27.23	5.69	10.43	13.24	16.16
EBITDA, 1 Yr. Growth %	23.06	-8.17	-27.1	27.88	13.85
EBITA, 1 Yr. Growth %	21.6	-12.28	-14.06	-9.64	10.49
EBIT, 1 Yr. Growth %	21.6	-12.28	-14.06	-9.64	10.49
Earnings From Cont. Operations, 1 Yr. Growth %	38.88	-12.93	-39.23	12.65	-12.01
Net Income, 1 Yr. Growth %	45.47	-17.07	-38.7	31.29	-25.73
Normalized Net Income, 1 Yr. Growth %	31.14	-22.51	-14.65	19.3	-27.97
Diluted EPS Before Extra, 1 Yr. Growth %	41.82	-19.1	-41.66	26.9	-25.73
Accounts Receivable, 1 Yr. Growth %	1.69	21.1	2.32	10.81	19.79
Inventory, 1 Yr. Growth %	288.86	96.59	35.79	15.59	24.79
Net Property, Plant and Equip., 1 Yr. Growth %	6.58	22.83	20.13	1.82	-0.57
Total Assets, 1 Yr. Growth %	34.53	18.43	19.75	6.05	11.52
Tangible Book Value, 1 Yr. Growth %	60.36	25.33	21.12	5.68	11.77
Common Equity, 1 Yr. Growth %	60.38	25.49	21.07	5.64	11.72
Cash From Operations, 1 Yr. Growth %	-81.05	-270.19	-57.38	13.96	269.02
Capital Expenditures, 1 Yr. Growth %	-61.74	153.27	7	-66.54	-26.26
Levered Free Cash Flow, 1 Yr. Growth %	163.18	211.27	-17.39	-51.43	33.45
Unlevered Free Cash Flow, 1 Yr. Growth %	174.04	219.5	-20.43	-56.75	34.71
Dividend Per Share, 1 Yr. Growth %	0	0	0	0	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.41	9.38	14.54	15.02	15.4
Gross Profit, 2 Yr. CAGR %	24.64	15.96	8.03	11.82	14.69
EBITDA, 2 Yr. CAGR %	27.68	6.31	-18.18	-3.45	20.66
EBITA, 2 Yr. CAGR %	19.18	3.3	-13.18	-11.88	-0.08
EBIT, 2 Yr. CAGR %	19.18	3.3	-13.18	-11.88	-0.08
Earnings From Cont. Operations, 2 Yr. CAGR %	24.65	9.98	-27.26	-17.26	-0.44
Net Income, 2 Yr. CAGR %	35.21	9.84	-29.53	-10.29	-1.25
Normalized Net Income, 2 Yr. CAGR %	29.01	0.79	-20.47	0.91	-7.3
Diluted EPS Before Extra, 2 Yr. CAGR %	33.53	7.11	-32.1	-13.96	-2.92
Accounts Receivable, 2 Yr. CAGR %	9.7	10.97	11.31	6.48	15.21
Inventory, 2 Yr. CAGR %	37.69	176.49	63.39	25.28	20.1
Net Property, Plant and Equip., 2 Yr. CAGR %	20.87	14.41	21.47	10.59	0.62
Total Assets, 2 Yr. CAGR %	21.97	26.22	19.09	12.69	8.75
Tangible Book Value, 2 Yr. CAGR %	27.66	41.77	32.92	13.13	8.68
Common Equity, 2 Yr. CAGR %	27.64	41.86	32.95	13.09	8.64
Cash From Operations, 2 Yr. CAGR %	39.5	-43.22	-14.84	-30.31	105.07
Capital Expenditures, 2 Yr. CAGR %	-47.43	-1.57	64.62	-40.16	-50.33
Levered Free Cash Flow, 2 Yr. CAGR %	-43	186.19	60.35	-36.66	-20.75
Unlevered Free Cash Flow, 2 Yr. CAGR %	-44.33	195.87	59.44	-41.34	-23.67
Dividend Per Share, 2 Yr. CAGR %	41.42	0	0	0	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	6.66	7.9	11.56	14.36	15.62
Gross Profit, 3 Yr. CAGR %	23.87	17.97	14.08	9.74	13.25
EBITDA, 3 Yr. CAGR %	26.94	14.4	-6.25	-5.05	2
EBITA, 3 Yr. CAGR %	20.57	7.62	-2.85	-12.01	-4.98
EBIT, 3 Yr. CAGR %	20.57	7.62	-2.85	-12.01	-4.98
Earnings From Cont. Operations, 3 Yr. CAGR %	17.83	10.61	-9.75	-15.84	-15.55
Net Income, 3 Yr. CAGR %	23.46	14.88	-10.27	-13.29	-15.77
Normalized Net Income, 3 Yr. CAGR %	16.96	8.84	-6.05	-8.96	-9.81
Diluted EPS Before Extra, 3 Yr. CAGR %	15.3	12.99	-13.2	-16.36	-18.08
Accounts Receivable, 3 Yr. CAGR %	10.38	13.37	8.01	11.15	10.74
Inventory, 3 Yr. CAGR %	21.08	55.04	118.14	45.58	25.12
Net Property, Plant and Equip., 3 Yr. CAGR %	50.03	21.52	16.29	14.53	6.74
Total Assets, 3 Yr. CAGR %	19.2	20.78	24.03	14.57	12.3
Tangible Book Value, 3 Yr. CAGR %	20.25	26.88	41.5	23.13	12.68
Common Equity, 3 Yr. CAGR %	20.22	26.92	41.53	23.14	12.63
Cash From Operations, 3 Yr. CAGR %	13.08	49.06	-48.4	-6.15	21.47
Capital Expenditures, 3 Yr. CAGR %	-4.75	-11.21	1.21	-3.21	-35.85
Levered Free Cash Flow, 3 Yr. CAGR %	-12.39	0.37	89.14	7.69	-19.64
Unlevered Free Cash Flow, 3 Yr. CAGR %	-13.15	-0.33	90.98	3.21	-22.61
Dividend Per Share, 3 Yr. CAGR %	0	25.99	0	0	0
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.9	8.57	9.75	10.69	13.08
Gross Profit, 5 Yr. CAGR %	17.25	14.31	17.27	15.47	14.33
EBITDA, 5 Yr. CAGR %	21.35	12.44	6.49	6.9	3.71
EBITA, 5 Yr. CAGR %	18.3	7.92	5.73	-0.65	-1.75
EBIT, 5 Yr. CAGR %	18.3	7.92	5.73	-0.65	-1.75
Earnings From Cont. Operations, 5 Yr. CAGR %	32.27	14.37	-2.84	-1.52	-6.14
Net Income, 5 Yr. CAGR %	36.19	18.51	-1.35	3.58	-6.77
Normalized Net Income, 5 Yr. CAGR %	28.85	11.44	0.23	4.66	-6.55
Diluted EPS Before Extra, 5 Yr. CAGR %	23.16	8.78	-6.71	0.85	-9.23
Accounts Receivable, 5 Yr. CAGR %	17.72	12.96	10.75	10.56	10.83
Inventory, 5 Yr. CAGR %	20.26	34.82	36.5	42.37	71.82
Net Property, Plant and Equip., 5 Yr. CAGR %	51.6	46.78	37.88	17.03	9.75
Total Assets, 5 Yr. CAGR %	38.98	30.66	19.15	17.47	17.67
Tangible Book Value, 5 Yr. CAGR %	92.8	49.22	25.17	24.92	27.32
Common Equity, 5 Yr. CAGR %	92.77	49.1	25.16	24.92	27.32
Cash From Operations, 5 Yr. CAGR %	6.6	21.97	0.96	9.97	-10.39
Capital Expenditures, 5 Yr. CAGR %	53.78	33.17	18.55	-24.18	-23.87
Levered Free Cash Flow, 5 Yr. CAGR %	53.71	28.23	11.57	-16.51	33.56
Unlevered Free Cash Flow, 5 Yr. CAGR %	212.87	29.94	10.73	-19.37	32.33
Dividend Per Share, 5 Yr. CAGR %	4.56	0	0	14.87	0